Free Trial

DLocal (DLO) Competitors

DLocal logo
$11.81 +0.22 (+1.90%)
As of 01/17/2025 04:00 PM Eastern

DLO vs. RTO, CART, ALLE, MEDP, ULS, WPP, GLOB, HQY, STN, and BILI

Should you be buying DLocal stock or one of its competitors? The main competitors of DLocal include Rentokil Initial (RTO), Maplebear (CART), Allegion (ALLE), Medpace (MEDP), UL Solutions (ULS), WPP (WPP), Globant (GLOB), HealthEquity (HQY), Stantec (STN), and Bilibili (BILI). These companies are all part of the "business services" industry.

DLocal vs.

DLocal (NASDAQ:DLO) and Rentokil Initial (NYSE:RTO) are both business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, community ranking, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

DLocal received 17 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 30.88% of users gave DLocal an outperform vote while only 30.77% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
DLocalOutperform Votes
21
30.88%
Underperform Votes
47
69.12%
Rentokil InitialOutperform Votes
4
30.77%
Underperform Votes
9
69.23%

Rentokil Initial has higher revenue and earnings than DLocal.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DLocal$650.35M5.38$148.96M$0.4029.53
Rentokil Initial$6.68B1.80$473.93MN/AN/A

90.1% of DLocal shares are held by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are held by institutional investors. 45.4% of DLocal shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

DLocal has a net margin of 16.35% compared to Rentokil Initial's net margin of 0.00%. DLocal's return on equity of 32.59% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
DLocal16.35% 32.59% 12.95%
Rentokil Initial N/A N/A N/A

DLocal currently has a consensus price target of $11.31, suggesting a potential downside of 4.21%. Rentokil Initial has a consensus price target of $29.00, suggesting a potential upside of 21.77%. Given Rentokil Initial's stronger consensus rating and higher probable upside, analysts clearly believe Rentokil Initial is more favorable than DLocal.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DLocal
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13
Rentokil Initial
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.63

DLocal has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500.

In the previous week, Rentokil Initial had 11 more articles in the media than DLocal. MarketBeat recorded 23 mentions for Rentokil Initial and 12 mentions for DLocal. DLocal's average media sentiment score of 0.22 beat Rentokil Initial's score of 0.12 indicating that DLocal is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DLocal
1 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Rentokil Initial
5 Very Positive mention(s)
0 Positive mention(s)
17 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

DLocal beats Rentokil Initial on 9 of the 16 factors compared between the two stocks.

Get DLocal News Delivered to You Automatically

Sign up to receive the latest news and ratings for DLO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DLO vs. The Competition

MetricDLocalBusiness services IndustryBusiness SectorNASDAQ Exchange
Market Cap$3.33B$20.37B$7.22B$8.96B
Dividend YieldN/A2.67%2.33%4.04%
P/E Ratio29.5327.5128.2217.32
Price / Sales5.386.3795.6678.69
Price / Cash17.7333.3829.1435.97
Price / Book7.675.806.194.79
Net Income$148.96M$526.53M$134.52M$225.07M
7 Day Performance5.16%3.09%1.26%1.52%
1 Month Performance0.25%5.01%5.82%4.68%
1 Year Performance-32.94%11.91%24.07%20.90%

DLocal Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DLO
DLocal
1.4713 of 5 stars
$11.81
+1.9%
$11.31
-4.2%
-32.4%$3.33B$650.35M29.53540Analyst Forecast
News Coverage
RTO
Rentokil Initial
2.1225 of 5 stars
$23.87
+1.9%
$29.00
+21.5%
-6.3%$12.05B$5.41B16.9362,900Short Interest ↓
CART
Maplebear
4.2289 of 5 stars
$44.31
+0.2%
$47.63
+7.5%
+80.4%$11.38B$3.30B29.743,380Analyst Upgrade
Short Interest ↓
ALLE
Allegion
4.0017 of 5 stars
$127.91
+1.3%
$140.83
+10.1%
+12.6%$11.12B$3.72B19.6511,000Analyst Downgrade
Short Interest ↑
Analyst Revision
News Coverage
MEDP
Medpace
4.5521 of 5 stars
$350.84
0.0%
$380.56
+8.5%
+18.4%$10.90B$2.07B30.725,900
ULS
UL Solutions
1.3572 of 5 stars
$50.07
+1.6%
$49.00
-2.1%
N/A$10.02B$2.82B0.0015,233Short Interest ↑
WPP
WPP
1.2619 of 5 stars
$43.88
-0.2%
N/A-0.7%$9.47B$14.85B7.46114,732
GLOB
Globant
3.9945 of 5 stars
$205.53
-0.9%
$230.44
+12.1%
-5.9%$8.86B$2.35B53.6629,150Short Interest ↑
News Coverage
Positive News
HQY
HealthEquity
3.1799 of 5 stars
$100.89
+0.6%
$110.71
+9.7%
+40.7%$8.74B$1.15B92.563,150
STN
Stantec
3.6565 of 5 stars
$76.35
+0.3%
N/A-1.5%$8.71B$7.15B34.7028,000
BILI
Bilibili
2.6735 of 5 stars
$16.09
+0.8%
$19.69
+22.4%
+78.1%$6.67B$25.45B-17.498,801Options Volume

Related Companies and Tools


This page (NASDAQ:DLO) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners